KURA ONCOLOGY, INC. Prepaid Expense and Other Assets, Current
KURA ONCOLOGY, INC. (KURA) had Prepaid Expense and Other Assets, Current of $28.48 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-12
- 2026-06-30: Prepaid Expense and Other Assets, Current $28.48M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $32.77M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $32.21M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $35.06M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $28.48M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $32.77M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $32.21M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $35.06M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $24.77M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $17.26M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $15.37M 10-K · filed 2026-03-05 | $17.43M 10-K · filed 2025-02-28 |
| 2024-09-30 | $7.89M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $8.25M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $10.71M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $8.52M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $7.32M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $8.67M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $10.55M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $8.44M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $8.62M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $9.53M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $6.96M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $4.33M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $5.46M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $6.14M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $6.83M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $3.97M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $3.50M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $3.32M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $4.16M 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $2.71M 10-K · filed 2021-02-24 | $2.68M 10-K · filed 2020-02-25 |
| 2019-09-30 | $2.77M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $2.38M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $1.88M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $1.99M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $2.74M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $2.42M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $1.90M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $1.28M 10-K · filed 2019-03-05 | |
| 2017-09-30 | $909.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.19M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $1.13M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $725.00K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $886.00K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $1.04M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $1.20M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $693.00K 10-K · filed 2017-03-14 | |
| 2015-09-30 | $695.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $884.00K 10-Q · filed 2015-08-14 | |
| 2014-12-31 | $42.00K 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |